Skip to NavigationSkip to content

News

0
Abbvie image
Company reports strong growth in the wake of Shire acquisition deal being liquidised
0
Lonza image
Firms inflate existing manufacturing agreement to meet demand  
0
Pradaxa image
Boehringer’s drug now licensed to treat blood clots in legs and lungs despite ongoing safety concerns
0
BMS image
The new PD-1 treatment could be a major blockbuster for the firm

Features

France image

George Underwood investigates a former jewel in the crown of Europe’s health industry that is now facing some tough questions